Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Arcadia Biosciences (RKDA) Long-Term Debt Repayments (2019 - 2021)

Arcadia Biosciences filings provide 3 years of Long-Term Debt Repayments readings, the most recent being $114000.0 for Q4 2021.

  • On a quarterly basis, Long-Term Debt Repayments rose 1325.0% to $114000.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $2.1 million, a 6211.76% increase, with the full-year FY2021 number at $2.1 million, up 6211.76% from a year prior.
  • Long-Term Debt Repayments hit $114000.0 in Q4 2021 for Arcadia Biosciences, up from $13000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $2.0 million in Q1 2021 to a low of $6000.0 in Q4 2019.
  • Median Long-Term Debt Repayments over the past 3 years was $10000.0 (2021), compared with a mean of $242888.9.
  • The widest YoY moves for Long-Term Debt Repayments: up 28600.0% in 2021, down 18.18% in 2021.
  • Arcadia Biosciences' Long-Term Debt Repayments stood at $6000.0 in 2019, then soared by 33.33% to $8000.0 in 2020, then surged by 1325.0% to $114000.0 in 2021.
  • The last three reported values for Long-Term Debt Repayments were $114000.0 (Q4 2021), $13000.0 (Q3 2021), and $10000.0 (Q2 2021) per Business Quant data.